Join us on 12-15-2022 for a live seminar about RNA SEQ

Click Here

Expert drug discovery services

Our Discovery Services augment your own expertise or give you capacity when you need it. Our team of leading scientists runs bespoke drug discovery campaigns for our partners and is continually innovating to validate and utilize cutting edge technology in our discovery offerings.

Expert drug discovery services

Our discovery services augment your own expertise or give you capacity when you need it. Our team of leading scientists runs bespoke drug discovery campaigns for our partners and is continually innovating to validate and utilize cutting edge technology in our discovery offerings.

OUR SERVICES

High-touch, expert campaigns for discovering therapeutics

Our world-class discovery team helps you find the best therapeutic antibody and TCR drug candidates to advance your early stage pipeline.

OUR DISCOVERY SERVICES IN ANTIBODIES AND TCRS:
DEEPIMMUNE ANTIBODY DISCOVERY
DAEDAMAB ANTIBODY DISCOVERY
KEYWAY TCR DISCOVERY
CAR-T DISCOVERY SERVICES
VENTURE STUDIO

Empowering new drug companies

Our venture studio 82VS activates Alloy’s platforms, discovery services groups, and company creation expertise to help brilliant scientific entrepreneurs efficiently advance new medicines pipelines.

Explore DeepImmune
HIGH VELOCITY, SEQUENCE-FIRST

Daedamab antibody discovery

Daedamab’s unique, sequencing-first approach blends extremely fast B cell sequencing and antibody synthesis to help Alloy partners find high quality therapeutic antibody candidates in less time.

Explore Daedamab
FOR NEXT-GEN IMMUNOTHERAPY

Keyway TCR discovery

Through an integrated service offering from target selection through to final characterized leads, Keyway empowers drug developers working against the 90% of proteins that aren’t accessible by conventional cancer immunotherapies.

Explore Keyway
FROM BINDERS TO FINAL CONSTRUCTS

CAR-T discovery services

We handle aspects of a CAR discovery program, from initial monoclonal antibody discovery, to engineering to CAR constructs, to transient and stable expression in various cell types, to final in vitro and in vivo characterization of functional CAR-T constructs in primary human T cells.

Schedule a call
ACCELERATE YOUR DRUG PROGRAM

Translational medicine services

We accelerate partner programs by providing early insights into functional activity of therapeutic candidates generated from Alloy discovery programs across all modalities. Generally, we offer these services in line with DeepImmune for human antibody discovery and Keyway for therapeutic TCR discovery, but we can offer advice and services on a case-by-case basis for our license partners and ecosystem collaborators.

In vivo antibody discovery

We empower discovers of monoclonal, bispecific, and single domain antibodies with royalty-free access to our platforms.
Alloy Therapeutics humanized mouse antibody drug discovery platforms

Our first platform, the ATX-Gx™, is the world’s fastest growing transgenic mouse platform for human monoclonal antibody discovery. Partners may ship mice to their labs, work with an ATX-Gx certified service provide, or engage with our flagship antibody discovery service, DeepImmune.

ATX-Gx™

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.

ATX-CLC

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.

ATX-SiD

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.

How can we help?

Learn more about licensing our platforms for use your lab or starting a campaign with DeepImmune.

Machine Learning

Deep learning optimized discovery

We’ve built a robust unique Deep Learning and sequencing engine that characterizes immune repertoire data, rapidly identifies novel binders, and optimizes candidates by scanning the breadth of sequence variants.

READ MORE

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.

Supporting drug makers across 6 biologic modalities

We are also active in genetic medicines, peptides, cell therapy, and drug delivery technology through new Venture Studio companies, discovery services, and internal innovation projects.

antibody drug discovery
TCR drug discovery
ASO genetic medicines discovery
ANTIBODIES

TCRS

GENETIC MEDICINES
peptides drug discovery
chimeric antigen receptor drug discovery
biologics drug delivery
PEPTIDES
CELL THERAPIES
DELIVERY

Learn more about our work in these areas.

Accept Privacy Settings Here
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please read and Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound